Insider Trading July 6, 2026 05:48 PM

Clearfield Chief Executive Officer Executes Pre-Arranged Share Sale Under Rule 10b5-1 Plan

CEO Cheryl Beranek divests 1,778 shares as company reports second-quarter 2026 earnings that miss consensus estimates.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
CLFD

Clearfield, Inc. (NASDAQ: CLFD) Chief Executive Officer Cheryl Beranek executed a sale of 1,778 shares of the company's common stock on July 1, 2026. The transaction, valued at $71,226, was conducted under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025. Following this divestment, Beranek retains direct ownership of 492,973 shares. The sale occurs as Clearfield reports fiscal second-quarter 2026 results that fell short of analyst expectations for both earnings per share and revenue, though the company maintains an optimistic forward outlook despite a high valuation multiple.

Clearfield Chief Executive Officer Executes Pre-Arranged Share Sale Under Rule 10b5-1 Plan
CLFD
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Executive share sales under Rule 10b5-1 plans are standard compliance mechanisms, but Beranek's sale occurs alongside disappointing Q2 results.
  • Clearfield's Q2 2026 earnings per share of -$0.04 and revenue of $34.4 million missed forecasts, reflecting near-term operational challenges.
  • The stock's high P/E ratio of 150.3 and recent 10% weekly decline suggest valuation pressure in the technology sector.

Clearfield, Inc. (NASDAQ: CLFD) Chief Executive Officer Cheryl Beranek sold 1,778 shares of common stock on July 1, 2026, realizing a total transaction value of $71,226. The divestment was executed at prices ranging between $40.00 and $40.25 per share, resulting in a weighted average sale price of $40.06. The transaction was facilitated under a Rule 10b5-1 trading plan, which Beranek established on December 15, 2025. This pre-arranged framework allows executives to trade company stock according to a predetermined schedule, insulating the transactions from potential allegations of insider trading.

Following the completion of this sale, Beranek's direct holdings in Clearfield common stock stand at 492,973 shares. The company's equity has experienced recent downward pressure, with the stock price declining to $34.96. This current valuation reflects a market capitalization of $473 million. Market data indicates a significant short-term decline, with the stock dropping nearly 10% over the preceding week. The company currently trades at a price-to-earnings ratio of 150.3, which valuation analysis suggests places the stock slightly above its calculated fair value.

Executive trading activity coincides with Clearfield's release of its fiscal second-quarter 2026 earnings results. The company reported an earnings per share (EPS) of -$0.04, missing the consensus forecast of -$0.02. Revenue for the quarter also fell short of expectations, coming in at $34.4 million against an anticipated $35.65 million. Despite these misses, management maintains an optimistic outlook for the future. Analyst coverage remains stable, with no recent upgrades or downgrades issued for the stock. Investors are closely monitoring these financial metrics to assess the company's underlying health.

Key Takeaways:

  • CEO Cheryl Beranek divested 1,778 shares under a Rule 10b5-1 plan, reducing her direct stake while retaining substantial ownership.
  • Clearfield's Q2 2026 financial results missed consensus estimates on both earnings and revenue, contributing to recent stock price weakness.
  • The company trades at a high P/E ratio of 150.3, with valuation models indicating the stock is slightly overvalued relative to its fair value.

Risks and Uncertainties:

  • The company's recent earnings and revenue misses highlight execution risks in its operational performance, which may impact investor confidence in the tech sector.
  • The high valuation multiple of 150.3 presents a risk if future growth does not justify the premium, potentially affecting the broader technology and infrastructure markets.
  • Continued stock price decline and negative earnings may signal broader market volatility for small-cap tech equities.

Risks

  • The company's failure to meet earnings and revenue forecasts introduces execution risk, which could affect investor sentiment in the tech sector.
  • A P/E ratio of 150.3 indicates high valuation expectations, creating risk if future performance does not justify the premium.
  • Continued stock price weakness may signal broader market volatility for small-cap technology equities.

More from Insider Trading

Director Mark Hancock Executes $7.3 Million PACS Group Sale Under Pre-Arranged Plan Jul 6, 2026 PACS Group Executive Trims Holdings Amid Strong Financial Performance Jul 6, 2026 Simulations Plus Director Walter Woltosz Executes $77,023 Stock Sale Under Pre-Arranged Plan Jul 6, 2026 Ionis Pharmaceuticals Director Joseph Klein III Executes $910k Stock Sale Under Pre-Arranged Plan Jul 6, 2026 Everspin Technologies VP Sales Sean Dougherty Sells $7,997 in Stock to Cover Tax Obligations Jul 6, 2026